A0A0B4J279 (TVA21_HUMAN) Homo sapiens (Human)

T cell receptor alpha variable 21 UniProtKBInterProInteractive Modelling

112 aa; Sequence (Fasta)

Available Structures

9 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0K0K1A5; P01848; P01850;
21-112
100
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0K0K1A5; P01848; P01850; P04439; P61769; P78358;
21-112
100
Structural and kinetic basis for heightened immunogenicity of T cell vaccines Heteromer
A0A0K0K1A5; P01848; P01850; P04439; P61769; P78358;
21-112
100
HLA Class I antigen Heteromer
A0A592; A0A5B9; P01848; P04439; P40967; P61769;
20-111
10010×EDO;GOL;SO4;
MAGE-A3 Reactive TCR in complex with Titin Epitope in HLA-A1 Heteromer
A0A578; A0A5B9; P01848; P04439; P61769; Q8WZ42;
21-112
94.56GOL; 11×SO4;
Engineered Human HLA_A2 MHC Class I molecule in complex with TCR and SV9 peptide Heteromer
A0A0K0K1A5; K7N5M4; K7N5N2; P04439; P61769;
21-112
100GOL;ACT;
MAGE-A3 reactive TCR in complex with MAGE-A3 in HLA-A1 Heteromer
A0A578; A0A5B9; P01848; P04439; P43357; P61769;
21-112
94.56SO4;
Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8, Beta Chain-TRBV7-8, Antigen-presenting gly… Heteromer
A0A5B9; P01848; P15813; P61769;
20-110
100NAG;JLS;
Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8 and Beta Chain-TRBV7-8 Heteromer
A0A5B9; P01848;
21-110
100.0

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
9c3e.1.Amonomer0.8321-112
100.00